Chronic kidney disease in children: the global perspective

Bradley A Warady, Vimal Chadha, Bradley A Warady, Vimal Chadha

Abstract

In contrast to the increasing availability of information pertaining to the care of children with chronic kidney disease (CKD) from large-scale observational and interventional studies, epidemiological information on the incidence and prevalence of pediatric CKD is currently limited, imprecise, and flawed by methodological differences between the various data sources. There are distinct geographic differences in the reported causes of CKD in children, in part due to environmental, racial, genetic, and cultural (consanguinity) differences. However, a substantial percentage of children develop CKD early in life, with congenital renal disorders such as obstructive uropathy and aplasia/hypoplasia/dysplasia being responsible for almost one half of all cases. The most favored end-stage renal disease (ESRD) treatment modality in children is renal transplantation, but a lack of health care resources and high patient mortality in the developing world limits the global provision of renal replacement therapy (RRT) and influences patient prevalence. Additional efforts to define the epidemiology of pediatric CKD worldwide are necessary if a better understanding of the full extent of the problem, areas for study, and the potential impact of intervention is desired.

Figures

Fig. 1
Fig. 1
Incidence (left) and prevalence of end-stage renal disease (ESRD) around the world in the 0–19 age group in 2003 [5]
Fig. 2
Fig. 2
Percent distribution of prevalent dialysis modality (left) and transplant rates in the 0–19 age group in 2003 [5]

References

    1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12.
    1. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13:37–40.
    1. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365:31–40.
    1. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lyderson S, Holmen J. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284.
    1. U.S. renal data system, USRDS 2005 (2005) Annual data report: Atlas of end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    1. U.S. renal data system, USRDS 2004 (2004) Annual data report: Atlas of end-stage Renal Disease in the Untied States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    1. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Eng J Med. 2004;350:2654–2662.
    1. National Kidney Foundation Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. K/DOQI clinical practice guidelines. Am J Kidney Dis. 2002;39:S1–S266.
    1. Chen MLW, Hsu C-Y. Should the K/DOQI definition of chronic kidney disease be changed? Am J Kidney Dis. 2003;42:623–625.
    1. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) (2005) 2005 annual report. The EMMES Corporation, Rockville, MD
    1. Pistor K, Olbing H, Scharer K. Children with chronic renal failure in the Federal Republic Germany: I. Epidemiology, modes of treatment, survival. Clin Nephrol. 1985;23:272–277.
    1. Lagomarsimo E, Valenzuela A, Cavagnaro F, Solar E. Chronic renal failure in pediatrics Chilean survey. Pediatr Nephrol. 1999;13:288–291.
    1. Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld L, Kohaut E, Fine R. Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. Pediatr Nephrol. 1998;12:328–337.
    1. Esbjorner E, Aronson A, Berg U, Jodal U, Linne T. Children with chronic renal failure in Sweden 1978–1985. Pediatr Nephrol. 1990;4:249–252.
    1. Deleau J, Andre JL, Briancon S, Musse JP. Chronic renal failure in children: an epidemiological survey in Lorraine (France) Pediatr Nephrol. 1994;8:472–476.
    1. Esbjorner E, Berg U, Hansson S. Epidemiology of chronic renal failure in children: a report from Sweden 1986–1994. Pediatr Nephrol. 1997;11:438–442.
    1. Schwartz GJ, Haycock GB, Edelmann CM, Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259–263.
    1. Furth SL, Powe NR, Hwang W, Neu AM, Fivush BA. Does greater pediatric experience influence treatement choices in chronic disease management? Dialysis modality choice for children with end-stage renal disease. Arch Pediatr Adolesc Med. 1997;151:545–550.
    1. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics. 2003;111:e382–e387.
    1. van der Heijden BJ, van Dijk PC, Verrier-Jones K, Jager KJ, Briggs JD. Renal replacement therapy in children: data from 12 registries in Europe. Pediatr Nephrol. 2004;19:213–221.
    1. Australia and New Zealand Dialysis and Transplant Registry. The 28th annual report. 2005 report-data to 2004.
    1. Gulati S, Mittal S, Gupta RK. Etiology and outcome of chronic renal failure in Indian children. Pediatr Nephrol. 1999;13:594–596.
    1. Hari P, Singla IK, Mantan M, Kanitkar M, Batra B, Bagga A. Chronic renal failure in children. Indian Pediatr. 2003;40:1035–1042.
    1. Sirin A, Emre S, Alpay H, Nayir A, Bilge I, Tanman F. Etiology of chronic renal failure in Turkish children. Pediatr Nephrol. 1995;9:549–552.
    1. Madani K, Otoukesh H, Rastegar A, Why SV. Chronic renal failure in Iranian children. Pediatr Nephrol. 2001;16:140–144.
    1. Hamed RMA. The spectrum of chronic renal failure among Jordanian children. J Nephrol. 2002;15:130–135.
    1. Anochie I, Eke F. Chronic renal failure in children: a report from Port Harcourt, Nigeria (1985–2000) Pediatr Nephrol. 2003;18:692–695.
    1. Hattori S, Yosioka K, Honda M, Ito H, Japanese Society for Pediatric Nephrology The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol. 2002;17:456–461.
    1. De Vecchi AF, Dratwa M, Wiedmann ME. Healthcare systems and end-stage renal disease: an international review-costs and reimbursement of ESRD therapies. N Eng J Med. 1999;14:31–41.
    1. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 2006;70:1107–1114.
    1. U.S. renal data system, USRDS 2001 (2001) Annual data report: Atlas of end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    1. Hoy WE. Renal disease in Australian aboriginals. Med J Aust. 1996;165:126–127.
    1. Pope JC, IV, Brock JW, III, Adams MC, Stephens FD, Ichikawa I. How they began and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol. 1999;10:2018–2028.
    1. Finnish Registry for Kidney Diseases (1999) Report 1998, Helsinki, p 7
    1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Eng J Med. 1998;339:1448–1456.
    1. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS, AIPRD Study Group Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin converting enzyme inhibition: a patient level metaanalysis. Ann Intern Med. 2003;139:244–252.
    1. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–1473.
    1. Verani RR. Obesity associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis. 1992;20:629–634.
    1. Kambham N, Markwitz GS, Valeri AM. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–1509.
    1. Soergel M, Schaefer F. Effect of hypertension on the progression of chronic renal failure in children. Am J Hypertens. 2002;15:53S–56S.
    1. Mitsnefes M, Ho PL, McEnery PT. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) J Am Soc Nephrol. 2003;14:2618–2622.
    1. Kamper AL, Strandgaard S, Leyssac P. Effect of enalapril on the progression of chronic renal failure: a randomized controlled trial. Am J Hypertens. 1992;5:423–430.
    1. Lewis EJ, Hunsicker LG, Raymond PB, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–1462.
    1. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Effect of angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 1996;334:939–945.
    1. The GISEN Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997;349:1857–1863.
    1. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.
    1. Ellis D, Vats A, Moritz M, Reitz S, Grosso MJ, Janosky JE. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr. 2003;143:89–97.
    1. Wuhl E, Mehls O, Schaefer F, ESCAPE Trial Group Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int. 2004;66:768–776.
    1. Bergman S, Key BO, Kirk KA, Warnock DG, Rostant SG. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis. 1996;27:341–346.
    1. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–2907.
    1. Brenner BM, Chertow GM. Congenital oligo nephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994;23:171–175.
    1. Furth Susan L., Cole Stephen R., Moxey-Mims Marva, Kaskel Frederick, Mak Robert, Schwartz George, Wong Craig, Muñoz Alvaro, Warady Bradley A. Design and Methods of the Chronic Kidney Disease in Children (CKiD) Prospective Cohort Study. Clinical Journal of the American Society of Nephrology. 2006;1(5):1006–1015.
    1. Warady BA, Alexander SR, Balfe JW, Harvey V. Peritoneal dialysis in children. In: Gokal R, Khanna R, Krediet R, Nolph K, editors. Textbook of peritoneal dialysis. 2. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2000.
    1. Bakkaloglu SA, Ekim M, Sever L, Noyan A, Aksu N, Akman S, Elhan AH, Yalcinkaya F, Oner A, Kara OD, Caliskan S, Anarat A, Dusunsel R, Donmez O, Guven AG, Bakkaloglu A, Denizmen Y, Soylemezoglu, Ozcelik G. Chronic peritoneal dialysis in Turkish children: a multicenter study. Pediatr Nephrol. 2005;20:644–651.
    1. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14:898–902.
    1. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte Hj. Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol. 2000;14:105–110.
    1. Bakkaloglu SA, Ekim M, Tumer N, Soylu K. The effect of CAPD on the lipid profile of pediatric patients. Perit Dial Int. 2000;20:568–571.
    1. Wood EG, Hand M, Briscoe DM, Donaldson LA, Yiu V, Harley FL, Warady BA, Ellis EN. Risk factors for mortality in infants and young children on dialysis: North American Pediatric Renal Transplant Cooperative Study. Am J Kid Dis. 2001;37:573–579.
    1. Gillen DL, Smith J, Stehman-Breen CO, Warady BA, McDonald R, Brandt JR, Wong CS. The survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation. (Abstract) J Am Soc Nephrol. 2006;17:667A.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren